ArticleCureus2024
Cytomegalovirus Colitis Mimicking Ulcerative Colitis Flare in an Immunocompromised Patient: A Challenging Diagnosis.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Seroprevalence of CMV infection in patients with active ulcerative colitis and underlying factors of pathogenicity.BMC infectious diseases · 2025Article
- A Triple Challenge: Cytomegalovirus and Ulcerative Colitis in a Human Immunodeficiency Virus-Positive Patient.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report details a 40-year-old male patient with a background of ulcerative colitis (UC), who presented with persistent bloody diarrhea refractory to standard treatment. The clinical picture was initially suggestive of a UC flare-up, prompting the continued use of immunosuppressive therapy. However, histopathological evaluation ultimately revealed cytomegalovirus (CMV) colitis, a condition that can mimic UC exacerbation but requires a distinct treatment approach. The patient's immunosuppressive therapy, essential for UC management, likely contributed to the reactivation of latent CMV infection, underscoring the complexity of managing such cases. This case underscores the critical importance of a multidisciplinary approach in differentiating between UC exacerbation and opportunistic infections such as CMV colitis, especially in immunocompromised patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.